(Q58964242)
Statements
Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study (English)
G F Fleming
R C Bentley
T Herzog
J Sorosky
L Vaccarello
1 August 2004